I don’t think the directors purchasing will make much difference, unless it is a huge amount of shares.
I do wonder what other shareholders make of the current share price. I would have thought that the disappointing cancellation of AZD0466 would have been fully incorporated in the price by now. The daily volume is pretty high. There are important results due by next month which analysts should have a value for since these are open trials.
Anyone?
SPL Price at posting:
16.5¢ Sentiment: Hold Disclosure: Held
